PURPOSE. During contact lens wear, the amount of lysozyme deposited on contact lenses varies depending on the lens material. The binding of lysozyme to some contact lens materials may result in a conformational change that denatures the protein to an inactive form. This investigation evaluated the effect that denatured lysozyme has on human corneal epithelial cells (HCECs) by measuring cell viability and the release of inflammatory cytokines.
L ysozyme, also known as muramidase, is an enzyme found in tears that is a component of the innate immune system, providing a first line of defense for the eye. Lysozyme kills grampositive bacteria, protecting the eye against pathogens. 1 This enzyme is a single chain of approximately 129 to 130 amino acids, 2, 3 and it cleaves bacterial cell wall peptidoglycan. 4, 5 As a result of the loss of the bacterial cell wall, the bacteria become osmotically fragile and lyse. 6, 7 Lysozyme in tears is secreted by the lacrimal glands and makes up approximately 20% to 30% of total protein in both the basal tears and reflex tears. 1 In the open eye environment, lysozyme and other antimicrobial molecules in the tears, along with the cleansing action of the tear flow, provide for a passive barrier defense system that eliminates pathogens without causing inflammation. 8 The amount of lysozyme deposited on contact lenses varies depending on the lens material. Silicone hydrogels deposit significantly lower levels of lysozyme than conventional hydrogels. 9 Additional factors that can influence lysozyme deposition on contact lenses are lens surface charge, 10 water content, 11 and contact lens cleaning solutions. 12 Protein deposition on conventional ionic hydrogel lenses occurs quickly, with deposition of lysozyme of approximately 55 lg per lens within 15 minutes, with a plateau of accumulation for daily-wear modality lenses after 6 days of approximately 1400 lg per lens. 13 Proteins normally maintain their unique three-dimensional structures as their functions are impacted by changes to enzyme active sites or protein binding specificities. However, on protein binding to some contact lens materials, a significant amount of protein denaturation may occur. Etafilcon A lenses sorb the most lysozyme compared with other contact lens materials, 14, 15 but on etafilcon A lenses only a small percentage of this protein becomes denatured. 15 In a study that evaluated the activity of lysozyme deposited on contact lenses soaked in different artificial tear solutions, it was determined that lysozyme on etafilcon A lenses was between 97% and 78% active throughout a 28-day soak period. Lotrafilcon B, senofilcon A, and omafilcon A, on the other hand, had less than 40% active lysozyme on the lenses after a 28-day soak. 16 Although lysozyme can be very beneficial to maintaining ocular health, if the protein denatures, or renatures forming new conformations of the proteins, or aggregates, it could trigger an immunological response. 17 Contact lens-induced papillary conjunctivitis (CLPC) is a major complication of contact lens wear and results in contact lens discontinuation. One hypothesis for the cause of CLPC is that it is an immunological response to denatured proteins on the surface of a contact lens. 18 Patients who replace their contact lenses more frequently have a reduced chance of developing CLPC, with lenses worn for longer than 30 days exhibiting more deposits and an increased incidence of CLPC than lenses replaced at less than 4 weeks. 19 If solely the amount of protein deposits on the lens was the main factor for irritation, it would be expected that etafilcon A lenses would be determined to be a risk factor in the development of CLPC because of the increased deposition of protein seen on these lenses compared with other contact lens materials. 16 However, etafilcon A lenses have a low incidence of CLPC after many years of use. 20 In addition, the amount of active lysozyme found on contact lenses correlated with contact lens comfort after 1 day wear of etafilcon A contact lens materials. 21 Given these results, it is clinically relevant to determine the impact of denatured and native lysozyme on cells from the ocular surface. In this study, the impact of lysozyme denaturation on ocular inflammation was investigated by exposing human corneal epithelial cells (HCECs) to native and denatured lysozyme and measuring corneal cell viability and the release of inflammatory cytokines.
METHODS

Cell Culture Conditions
Both primary and immortalized HCEC lines were used. Primary HCEC cultures from three separate donors were obtained from Millipore (Billerica, MA, USA) and American Type Culture Collection (ATCC; Manassas, VA, USA). Immortalized (SV-40 transformed) HCEC was a gift from Dr. M. Griffith, Ottawa Eye Research Institute, Ottawa, Canada. The primary culture was the focus of this investigation and was tested in all assays. The immortalized culture was evaluated only in the confocal microscopy evaluation. The primary HCECs were grown in EpiGRO Human Ocular Epithelia Media (Millipore) supplemented with the manufacturer's kit components: 6 mM LGlutamine, 0.002% EpiFactor O, 1.0 lM epinephrine, 0.4% EpiFactor P, 5 lg/mL rh insulin, 5 lg/mL Apo-Transferrin, and 100 ng/mL hydrocortisone. The immortalized HCECs were grown in Dulbecco's Modified Eagle's Medium/Nutrient Mixture F12 (DMEM/F12) (Gibco, Grand Island, NY, USA) without phenol red, supplemented with 10% fetal bovine serum (Gibco) and 100 units/mL penicillin, 100 lg/mL streptomycin (Gibco). Both the primary and immortalized cells were propagated in Collagen-1 coated culture flasks at 378C with 5% CO 2 , and medium was replaced every 2 to 3 days. Benzalkonium chloride (Sigma-Aldrich, St. Louis, MO, USA) was used as a control solution for the confocal studies. Once enough cells were propagated for testing, cells were transferred to 24-well Collagen-1-coated culture plates. Cells were dissociated from the culture flask using TrypLE Express (Gibco) without phenol red and seeded in the wells at a concentration of 10 5 cells in 1 mL of cell media. Cells were incubated at 378C with 5% CO 2 for 1 day to allow for adherence before testing. After 1 day of growth, the cultures were subconfluent.
Preparation of Lysozyme
Lysozyme was dissolved in PBS (Lonza, Walkersville, MD, USA) at a concentration of 20 mg/mL. The lysozyme solution was filtered using a 0.22-lm filter. The filtered lysozyme solution was then transferred into five glass tubes and heated in a water bath at 1008C to denature the protein. Each tube was heated for a different length of time (3 minutes, 5 minutes, 10 minutes, and 15 minutes) to achieve different degrees of denaturation. One tube was not exposed to any heat, and thus this lysozyme remained in its native state.
Lysozyme Activity
The activity of the lysozyme for each time point was determined by the rate of lysis of Micrococcus lysodeikticus (Sigma-Aldrich). 22 Micrococcus lysodeikticus was dissolved in 10 mg/10 mL PBS with 1% BSA. The bacteria were allowed to swell in the solution overnight at 48C. The kinetic absorbance of the bacterial solution at optical density (OD) 450 was set to 1.0 to 1.1, and 1 mL of the bacteria solution was dispensed into each well of a clear 48-well plate. PBS was added to the control wells in triplicate. The prepared lysozyme solutions were then rapidly added to the wells in triplicate using a multichannel pipette, at a concentration of 500 ng/mL. The kinetic absorbance was measured for 30 minutes at 30-second intervals at OD 450. The enzyme activities of the four denatured, heated lysozyme solutions were measured as a proportion of enzyme activity of the native, unheated lysozyme.
Lysozyme Exposure
As previously described, HCECs were grown to subconfluence in a Collagen-1 coated 24-well plate. Additional cells were grown on MatTek glass-bottom collagen-coated dishes to subconfluence for confocal analysis. Cell growth media was removed, and cells were rinsed with 1 mL PBS. The wells were then replaced with fresh media. For the immortalized HCECs, the original growth media was replaced with DMEM/F12 without phenol red or serum, as serum proteins may interfere with the study results. Lysozyme that was denatured to different activity levels was then added to the growth media, diluting the lysozyme to 1.9 mg/mL. HCECs were exposed to the following test solutions in quadruplicate: (1) negative control: cell media with 100 lL PBS, (2) 1.9 mg/mL of native lysozyme in growth media, (3) 1.9 mg/mL of denatured lysozyme (heated for 3 minutes) in growth media, (4) 1.9 mg/mL of denatured lysozyme (heated for 5 minutes) in FIGURE 3. In the top two micrographs, PBS added to the growth media did not cause damage to the primary corneal epithelial cells after 24-hour incubation. In the bottom two micrographs, 0.001% BAK in cell culture media caused significant damage to the corneal epithelial cells. growth media, (5) 1.9 mg/mL of denatured lysozyme (heated for 10 minutes) in growth media, and (6) 1.9 mg/mL of denatured lysozyme (heated for 15 minutes) in growth media.
The total volume in the well was 1 mL, and a physiological concentration of lysozyme (1.9 mg/mL) was used. The total volume in the culture dishes used for the confocal microscopy study was 3 mL, and a physiological concentration of lysozyme (1.9 mg/mL) was used. The HCECs were incubated with the test solutions for 24 hours at 378C with 5% CO 2 .
Metabolic Activity Assay
After incubation, the wells were replaced with 1 mL of a solution containing DMEM/F12 media (without phenol red or serum) and 10% alamarBlue cell viability reagent (Invitrogen, Burlington, Ontario, Canada). The HCECs were incubated with the alamarBlue reagent for 4 hours at 378C with 5% CO 2 . DMEM/F12 media has been used previously in primary 23 and immortalized HCECs 24, 25 as the base media during the 4-hour reduction of alamarBlue to its reduced form (resazurin to resorufin). After 4 hours, 100 lL of the solution was removed from the wells and deposited in a clear 96-well plate. Fluorescence of the solution was measured at excitation/ emission wavelengths set at 530/590 nm using a SpectraMax fluorescence multiwell plate reader (Molecular Devices, Sunnyvale, CA, USA). Five separate experiments were performed using primary corneal epithelial cells. In each experiment, four replicates were performed for each treatment.
Confocal Microscopy Study
After incubation, the medium was removed from each dish, and the dish was rinsed with 1 mL PBS. The cells were then stained with annexin V (Invitrogen) 10 lL in 500 lL buffer, calcein AM (Invitrogen) 2 lM, and ethidium homodimer-1 (EthD-1) (Invitrogen) 4 lM, for 15 minutes at 378C. After staining, the fluorescence of the three dyes was then visualized with an Axiovert 100 microscope with a Zeiss confocal laser scanning microscope 510 system (Carl Zeiss, Toronto, Canada). The excitation/emission wavelengths for calcein AM, EthD-1, and annexin V, were 495/515 nm, 528/617 nm, and 650/665 nm, respectively. Four separate experiments were performed (two experiments using primary cells and two experiments using immortalized cells). In each experiment, three replicates were performed for each treatment, thus six replicates for each treatment were evaluated for each cell line.
Cytokine Analysis
After 24 hours of incubation with the test samples, the medium was removed from the wells, and transferred into sterile 2-mL polypropylene tubes and frozen at À808C for further cytokine analysis. Three experiments were performed. Each experiment was performed using primary cells from a different cell donor. The level of cytokines released by the primary cell culture after exposure to the test articles was quantified using the MesoScale Discovery (MSD) MESO QuickPlex SQ 120 imager (Gaithersburg, MD, USA). Using the MSD Proinflammatory Panel 1 V-Plex Assay Kit, 10 proinflammatory cytokines were 
Statistical Analysis
For the alamarBlue assay and cytokine analysis, the statistical significance of differences between treatment groups was determined using the Kruskal-Wallis test. Pairwise multiple comparison procedures were performed using Dunn's multiple comparisons test. Differences were considered significant when the probability was less than 0.05. Statistical significance between treatment groups for the heated lysozyme was determined using ANOVA, with comparison between groups with the Tukey's post hoc. Differences were considered significant when the probability was less than 0.05.
RESULTS
Heating the lysozyme in a 1008C water bath effectively denatured the lysozyme and reduced its activity (Fig. 1A) All groups were significantly different from the control and the other treatment groups (P < 0.05). At 3 minutes, the enzyme retained 67% of its activity, and by 15 minutes, the enzyme was almost completely denatured, retaining only 5% activity (Fig.  1) . Denatured lysozyme showed a decrease in activity in correspondence with the amount of time exposed to heat.
Cell Metabolic Activity
The study results indicate that primary HCEC treated with denatured lysozyme with 67%, 47%, and 22% activity, heated for 3, 5, and 10 minutes, respectively, showed a significant reduction in metabolic activity when compared with both the controls (media with 100 lL PBS) and cells treated with the native lysozyme (Fig. 1B) . There was no significant difference in metabolic activity between the controls and the cells treated with native lysozyme. The denatured lysozyme with 5% activity lysozyme that was heated for 15 minutes, respectively, showed no significant reduction in cell metabolic activity compared with the controls.
Confocal Microscopy
Images of the differential staining of live and dying cells are shown in Figure 2 . Ethidium homodimer-1 penetrates the cell membranes of dead or dying cells. Annexin V stains the cell membranes of either apoptotic or necrotic cells, and membrane blebbing can be seen in cells undergoing apoptosis. Calcein AM turns green after reaction with esterases within a cell, and this activity along with the absence of EthD-1 and annexin V staining shows cells that are alive.
When cells are exposed to PBS added to the growth media, the cells remain healthy, as shown in Figure 3 . The cells were not permeable to EthD-1 and stained with calcein. Cells exposed to benzalkonium chloride (BAK) were severely damaged and were either dead or dying, as shown by the penetration of EthD-1 through the cell membranes. Primary HCECs exposed to native and denatured lysozyme were mainly live cells. These cells stained with calcein and only a few cells stained with EthD-1 (Fig. 4) .
Immortalized HCECs exposed to native and denatured lysozyme were mainly live cells. These cells stained with calcein and only a few cells stained with EthD-1 (Fig. 5) . The control cultures treated with media with PBS stained primarily for calcein and the BAK control stained with EthD-1 and annexin V.
The Table shows viability of HCECs exposed to lysozyme solutions containing different lysozyme activity levels. Four confocal micrographs (225 3 225-lm areas) of each culture dish were taken, and the number of calcein-, EthD-1-, and annexin V-stained cells determined. Based on the staining, the cultures were given one of three viability outcomes: high, moderate, or low viability.
Release of Inflammatory Cytokines
Exposure of HCECs to the denatured lysozyme also caused a significant increase in the release of several inflammatory cytokines (IFN-c, IL-2, IL-4, IL-6, IL-8, IL-12p70, IL-13, IL-1b, IL-10, and TNF-a) from the primary HCECs (all P < 0.05), depending on the level of denatured lysozyme in contact with the cells (Figs. 6, 7) .
DISCUSSION
This study looked at three different measures of biocompatibility to assess the effect of native and denatured lysozyme on HCECs. The first measure used three different viability dyes to determine if the cells exposed to the protein were alive or undergoing apoptosis or necrosis. Using calcein, EthD-1, and annexin V, it was shown that HCEC exposure to neither native nor denatured lysozyme resulted in cell death. All of the cells exposed to both native and denatured lysozyme stained strongly for calcein, demonstrating that the cells were alive. The second measure of biocompatibility assessed whether there was an effect of the proteins on the metabolic activity within the cells. Using alamarBlue to measure metabolic activity, there was a drop in the metabolic activity of the cells exposed to 67%, 47%, and 22% active lysozyme. The third measure of biocompatibility determined if denatured lysozyme could cause a release of inflammatory cytokines from the HCECs. A significant increase in the release of several inflammatory cytokines (IFN-c, IL-2, IL-4, IL-6, IL-8, IL-12p70, IL-13 IL-1b, IL-10, and TNF-a) from the HCECs (all P < 0.05) was observed depending on the level of denatured lysozyme exposed to the cells. Overall, the results show that denatured lysozyme does not cause cell death but could affect the functionality of HCECs.
The concentration of lysozyme in the tears of healthy subjects is approximately 2.11 mg/mL 6 1.5 mg/mL. 26 In this investigation, we incubated the HCECs in 1.9 mg/mL native lysozyme and 1.9 mg/mL lysozyme at four different levels of denaturation. Lysozyme structure in its native form consists of one a-helix and one b-sheet. When lysozyme is denatured, the polypeptide chain will unfold and lose enzyme activity. 27, 28 Under the right conditions, lysozyme can then aggregate with other unfolded lysozyme molecules and form amyloid fibrils. Amyloids are proteins that have a strong tendency to self- , and TNF-a from the primary HCECs after 24-hour exposure to native and denatured lysozyme (67%, 47%, 22%, and 5% active). *P < 0.05 compared with CTRL. Error bars: SD. Concentration ¼ pg/mL. CTRL is 100 lL PBS in media.
FIGURE 7. The release of IL-10 and IL-13 from the primary HCECs after 24-hour exposure to native and denatured lysozyme (67%, 47%, 22%, and 5% active). *P < 0.05 compared with CTRL. Error bars: SD. Concentration ¼ pg/mL. CTRL is 100 lL PBS in media.
aggregate into polymeric fibrillar structures. 29 Fibrillization of proteins usually occurs when the proteins are partially unfolded or partially folded. 30 Lysozyme is one of the proteins that has been shown to form amyloid fibrils when it is partially unfolded. 31 The results show that loss of metabolic activity and cytokine release occurs mainly in the intermediate stages of denaturation (67%, 47%, and 22% activity) but not at the stage of almost complete denaturation (5% activity). Because mainly partially unfolded proteins favor fibrillization, it is possible that when denaturation goes past a threshold amount, fibrillization may no longer occur. This may explain why the most denatured (5% activity) did not cause a decrease in metabolic activity and less total cytokine release in HCECs.
Amyloid oligomers and amyloid fibrils have been demonstrated to be cytotoxic and cause a number of human diseases. [32] [33] [34] Various mechanisms of amyloid fibril cytotoxicity have been proposed, including altering cell permeability, 35 mitochondrial toxicity, 36 and concentration of misfolded proteins in the endoplasmic reticulum. 37 In this investigation, we found that denatured lysozyme caused a decrease in the metabolic activity of cells at intermediate denaturation levels of lysozyme. This result is consistent with the characteristic of amyloid formation that occurs mainly when proteins are partially unfolded. Also, lysozyme amyloid oligomers have been shown to be capable of causing damage to mitochondria and energy metabolism. 38 In addition to causing a reduction in the metabolic activity of HCECs, denatured lysozyme also caused an increase in the release of inflammatory cytokines. Amyloid plaques in Alzheimer's disease have been shown to stimulate microglial cells to release IL-1 and IFN-c in vitro 39 and in vivo in rats with high concentrations of amyloid deposition released high concentrations of TNF-a, IL-6, IL-12p40, and IL-1b in their tissues. 40 In AMD, Amyloid-beta is a constituent of AMD drusen and upregulates the production of IL-1b, IL-6, and TNF-a. 41 In our investigation, we determined that denatured lysozyme can cause the release of inflammatory molecules from HCECs. A chronic release of cytokines from ocular surface cells could cause the development of chronic inflammation consistent with the inflammation seen in other amyloid-associated diseases. The rationale for using the cytokines evaluated in this study is that all of the cytokines tested have been found in the tears of contact lens wearers. 42, 43 Also, elevated cytokine levels of IL-2, IL-4, IL-6, IL-10, IFN-c, TNF-a, IL-1b, and IL-8 have been found in the tears of dry eye patients. 44 Recently, it has been shown that the ratio of pro-and anti-inflammatory cytokines present in the tears of contact lens wearers (IL-1b to IL-10 and IL-12p70 to IL-10) may influence contact lens comfort. 45 The results of this investigation suggest a mechanism by which denatured lysozyme on the surface of the eye could cause the development of ocular surface changes. We show that denatured lysozyme can interfere with the metabolism of HCECs and cause the release of inflammatory cytokines. Reducing metabolic activity may cause changes in cell proliferation and thus affect the function of HCECs to maintain the barrier function of the eye. Causing an increase in the release of inflammatory cytokines could make the eye more susceptible to proliferation of inflammatory cells and their maturation. Previous studies have demonstrated that the proteins deposited on contact lenses denature, and this denaturation depends on the chemistry of the lens material, duration of contact, and the location of the protein on the contact lens. By finding ways to decrease corneal exposure to denatured protein, the biocompatibility of contact lenses may be improved, and this can potentially result in improved ocular biocompatibility.
CONCLUSIONS
The results of this study, for the first time, show that denatured lysozyme can have a detrimental effect on HCECs. Both a reduction in metabolic activity and the release of inflammatory cytokines occurred after HCECs were exposed to denatured lysozyme. Preventing proteins such as lysozyme from denaturing due to deposition on contact lenses may be desired to preserve corneal cell homeostasis essential for successful contact lens wear.
